期刊文献+

microRNA-10a-5p在喉癌前病变组织中的表达 被引量:1

Expression of microRNA-10a-5p in laryngeal epithelial premalignant lesions
原文传递
导出
摘要 目的:探讨microRNA-10a-5p(miR-10a)在喉癌前病变(LEPL)组织中表达的差异,并结合临床因素进行病理分析。方法参考WHO头颈部肿瘤病理学和遗传学(2005)分类系统,运用实时定量聚合酶链式反应方法检测miR-10a在94例LEPL组织中[轻度异型增生( MID)、中度异型增生( MOD)、重度异型增生( SD)及原位癌( CIS)]的表达,并比较各组间的表达差异,结合临床资料及随访结果分析miR-10a与各组别LEPL患者临床因素的相关性。结果随着LEPL异型程度的增加, miR-10a在LEPL组织中呈下调表达趋势,且在低风险病变组( MID+MOD)与高风险病变组( SD+CIS)之间的表达差异具有统计学意义(P=0.03);线性回归分析显示miR-10a与LEPL患者的性别、组织异型增生的程度存在线性相关( P<0.05)。结论 miR-10a在不同级别LEPL组织中的表达呈下调趋势,可为LEPL病理分级和早期喉癌诊断提供辅助参考。 Objective To investigate the expression of microRNA-10a-5p ( miR-10a) in laryngeal epithelial premalignant lesions ( LEPL ) and to analyze the correlations of its dys-regulation with clinicopathologic parameters of LEPL.Methods According to the WHO classification (2005), 94 cases of LEPL were grouped into mild dysplasia (MID), moderate dysplasia (MOD), severe dysplasia (SD) and carcinoma in situ (CIS).The expression of miR-10a in 94 cases of LEPL was detected by quantitative real-time polymerase chain reaction ( qRT-PCR) , and correlated with the clinical and follow-up data of all LEPL patients.Results miR-10a was down-regulated in LEPL with increasing grade of dysplasia.There was significantly statistical difference between low-risk ( MID+MOD) and high-risk ( SD+CIS) lesion groups ( P=0.03).The linear regression analysis showed that miR-10a was correlated with grade and gender of LEPL (P〈0.05).Conclusions Down regulation of miR-10a may be a useful molecular marker for grading of LEPL and diagnosis of early laryngeal cancer.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2015年第3期184-188,共5页 Chinese Journal of Pathology
基金 高等学校博士学科点专项科研基金(20131107110004) 2014年度科技创新基地培育与发展工程专项项目(Z141107004414028)
关键词 喉肿瘤 聚合酶链反应 病理学 临床 Laryngeal neoplasms Polymerase chain reaction Pathology,clinical
  • 相关文献

参考文献22

  • 1Bouquol JK, Gnepp DR. I>aryngeal precanoer: a review of theliterature, commentary, and comparison with oral leuk.plakia[ J].Head Neck,1991 ,13(6) :488-497.
  • 2Koturbasha I, Zempa FJ, Pogril)ny I,et al. Small molw.ules withbig effects : the role of the micmRNAome in <*ancer amicarcin()genesis[ J]. Mulal Kes,2011 ,722(2) : 94-105.
  • 3Long MJ,Wu FX, Li P,et al. MicroRNA-10a targets CHU amipromotes cell growth, migration and invasion in human cervicalcuncer cells[ J]. Cancer l^U ,2012 ,324( 2) : 186-196.
  • 4Hui AB, l^enanluzzi M, Krushel T, et a!. ComprehensiveMicroRNA profiling for head and neck squamous cell carcinomas[J].Clin Cancer Res,20I0 ,16( 4) ; 1129-1139.
  • 5Ovcharenko I), StMzel F, Poitz I), el al. miR-lOa overexpressionis assorialed with NPM1 mutations and MDM4 downregulation ininlermediate-risk acute myeloid leukemia [ J ]. Exp Hematol,2011 ,39(10) : 1030-1042.
  • 6Barnes Lt Eveson JW, Reichartl P, el al. WHO ('lassificalion oftumoufs of pathology and genetics of head ami neck lumours[ M] .Lyon: I ARC Press, 2005 : 140-143.
  • 7Sarioglu S, Cakalagaoglu F, Klagoz S, el al. Inler-ohserveragreement in laryngeal pre-neoplastic lesions [ J ]. Head NeckPathol,2010,4(4) :276-280.
  • 8Hu Y,Liu H. Diagnostic* variability of laryngeal premalignantlesions: histological evaluation and carcinoma Iransformation[ J ].Otolaryngol Head Neck Surg,2014 ,150(3 ) : 401-406.
  • 9Mirisoia V,Mora R, Esposito Al, et a). A prognostic mulligeneclassifier for squamous cell (*an*inomas of ihe larynx [ J ] - CancerLeu,2011,307(1): 3746.
  • 10Marioni G, Marchese-Ragona R, Cartei G, et al. Current opinionin diagnosis and treatment of laryngeal carcinoma [ J ]. CancerTreat Rev,2006,32(7) : 504-515.

共引文献43

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部